Report of Foreign Issuer (6-k)

Date : 05/13/2019 @ 9:35PM
Source : Edgar (US Regulatory)
Stock : Glaxosmithkline (GSK)
Quote : 40.63  0.04 (0.10%) @ 12:24AM

Report of Foreign Issuer (6-k)

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of May, 2019
 
Commission File Number 001-15170
 
 
GlaxoSmithKline plc
(Translation of registrant's name into English)
 
 
 980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an ris .
 
Date:  13 May 2019
 
Name of  applicant :
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
 
Period of return:
 
From:
 
1 November 2018
 
To:
 
30 April 2019
 
Balance of unallotted securities under scheme(s) from previous return:
 
547,331
 
Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
 
Less:   Number of  securities  issued/allotted under scheme(s) during period (see LR3.5.7G):
 
393,607
 
Equals:   Balance under scheme(s) not yet issued/allotted at end of period:
 
153,724
 
 
  
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
  
BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an ris .
 
Date:  13 May 2019
 
Name of  applicant :
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline Share Option Plan - Ordinary Shares
 
Period of return:
 
From:
 
1 November 2018
 
To:
 
30 April 2019
 
Balance of unallotted securities under scheme(s) from previous return:
 
2,223,352
 
Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less:   Number of  securities  issued/allotted under scheme(s) during period (see LR3.5.7G):
 
958,344
 
Equals:   Balance under scheme(s) not yet issued/allotted at end of period:
 
1,265,008
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an ris .
 
Date:  13 May 2019
 
Name of  applicant :
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline Share Option Plan - ADS
 
Period of return:
 
From:
 
1 November 2018
 
To:
 
30 April 2019
 
Balance of unallotted securities under scheme(s) from previous return:
 
7,336,096
 
Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less:   Number of  securities  issued/allotted under scheme(s) during period (see LR3.5.7G):
 
1,424,800
 
Equals:   Balance under scheme(s) not yet issued/allotted at end of period:
 
5,911,296
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an ris .
 
Date:  13 May 2019
 
Name of  applicant :
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline plc Share Save Plan 2012
 
Period of return:
 
From:
 
1 November 2018
 
To:
 
30 April 2019
 
Balance of unallotted securities under scheme(s) from previous return:
 
5,672,623
 
Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less:   Number of  securities  issued/allotted under scheme(s) during period (see LR3.5.7G):
 
3,345,727
 
Equals:   Balance under scheme(s) not yet issued/allotted at end of period:
 
2,326,896
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
 
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

 
GlaxoSmithKline plc
 
(Registrant)
 
 
Date: May 13, 2019
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GlaxoSmithKline plc
 
 
 
 

Glaxosmithkline (NYSE:GSK)
Historical Stock Chart

1 Year : From Jun 2018 to Jun 2019

Click Here for more Glaxosmithkline Charts.

Glaxosmithkline (NYSE:GSK)
Intraday Stock Chart

Today : Tuesday 25 June 2019

Click Here for more Glaxosmithkline Charts.

Latest GSK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.